About Company
Lucence is a precision oncology company founded on a vision of a world without avoidable cancer deaths. The Company develops advanced liquid biopsy blood tests that select suitable cancer treatments by molecular profiling. Headquartered in Singapore and California, with offices in Hong Kong and Suzhou, Lucence supplies molecular diagnostic services for innovative cancer testing worldwide through a US CLIA-licensed, CAP and ISO15189-accredited laboratory.
